CJC/Ipa Blend

The CJC-1295/Ipamorelin Blend combines two peptides with complementary mechanisms to enhance growth hormone (GH) regulation. CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed with a drug affinity complex (DAC) to extend its half-life, allowing for sustained GH release. It acts on the pituitary gland to increase endogenous GH and insulin-like growth factor-1 (IGF-1) levels, supporting long-term anabolic and regenerative processes.

Ipamorelin, a selective growth hormone secretagogue, works by binding to the ghrelin receptor (GHS-R1a) to stimulate pulsatile GH release without significantly affecting cortisol or prolactin levels. The combination of sustained GH elevation from CJC-1295 and precise GH pulses from Ipamorelin offers a synergistic approach, making this blend a focal point in studies on body composition, recovery, and age-related declines in GH production.